Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 11.70
+0.30 (2.63%)
Oct 19, 2026, 3:50 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 241.08 million as of October 19, 2026. It is the 35,779th most valuable company in the world and the 489th biggest in Sweden. Its market cap has decreased by 49.79% in one year.
Market Cap
241.08M
Enterprise Value
255.30M
Revenue
83.30M
Global Rank
Country Rank
#489 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 241.08M, an increase of 83.96%. That is a compound annual growth rate of 5.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 241.08M | 14.71% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 374.58M |
| Corline Biomedical AB | 369.78M |
| Cantargia AB | 368.22M |
| Mendus AB | 358.10M |
| IRLAB Therapeutics AB | 300.40M |
| Intervacc AB | 279.81M |
| Isofol Medical AB | 264.73M |
| Elicera Therapeutics AB | 193.20M |